JAGX
JAGX
NASDAQ · Pharmaceuticals

Jaguar Health Inc

$3.00
+0.02 (+0.67%)
As of May 9, 2:30 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,496.7% upside
Low Target $35.39
Average Target $47.90
High Target $54.68
Current Price $3.00
Current
$3.00
Target
$47.90
$35.39 $47.90 avg $54.68
Scenario Analysis
Bear Case
$35.39
1,079.7%
Low target
Base Case
$47.90
+1,496.7%
Avg target
Bull Case
$54.68
+1,722.7%
High target
Risk/Reward
1.6x
Balanced
Price in Context
Target vs 52W High
$47.90
-87.9% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-2.08
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%